Company · Toronto, Ontario, Canada
Pentapharm Ltd.
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 67
- 0 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 3
- 3 active
- Notices of Compliance
- 35
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| PENTA-ACEBUTOLOL TABLETS | 02231251 | Cancelled (Unreturned Annual) | |
| PENTA-ACEBUTOLOL TABLETS | 02231252 | Cancelled (Unreturned Annual) | |
| PENTA-ACEBUTOLOL TABLETS | 02231253 | Cancelled (Unreturned Annual) | |
| PENTA-AMILORIDE HCTZ TABLETS | 02231254 | Cancelled (Unreturned Annual) | |
| PENTA-AMOXICILLIN | 02233017 | Cancelled (Unreturned Annual) | |
| PENTA-AMOXICILLIN - 125MG/5ML | 02229582 | Cancelled (Unreturned Annual) | |
| PENTA-AMOXICILLIN - 250MG CAPSULES | 02229584 | Cancelled (Unreturned Annual) | |
| PENTA-AMOXICILLIN - 250MG/5ML | 02229583 | Cancelled (Unreturned Annual) | |
| PENTA-ATENOLOL - 100MG | 02229586 | Cancelled (Unreturned Annual) | |
| PENTA-ATENOLOL - 50MG | 02229585 | Cancelled (Unreturned Annual) | |
| PENTA-BACLOFEN TABLETS | 02239075 | Cancelled (Unreturned Annual) | |
| PENTA-BACLOFEN TABLETS | 02239076 | Cancelled (Unreturned Annual) | |
| PENTA-BROMAZEPAM TABLETS | 02232556 | Cancelled Post Market | |
| PENTA-BROMAZEPAM TABLETS | 02232558 | Cancelled (Unreturned Annual) | |
| PENTA-BUSPIRONE | 02238613 | Cancelled (Unreturned Annual) | |
| PENTA-CAPTOPRIL TABLETS | 02234254 | Cancelled (Unreturned Annual) | |
| PENTA-CAPTOPRIL TABLETS | 02234255 | Cancelled (Unreturned Annual) | |
| PENTA-CAPTOPRIL TABLETS | 02234256 | Cancelled (Unreturned Annual) | |
| PENTA-CAPTOPRIL TABLETS | 02234257 | Cancelled (Unreturned Annual) | |
| PENTA-CEPHALEXIN - 250MG | 02229587 | Cancelled Post Market | |
| PENTA-CEPHALEXIN - 500MG | 02229588 | Cancelled Post Market | |
| PENTA-CLOBETASOL CREAM | 02232548 | Cancelled (Unreturned Annual) | |
| PENTA-CLOMIPRAMINE - 25MG | 02229589 | Cancelled Post Market | |
| PENTA-CLOMIPRAMINE - 50MG | 02229590 | Cancelled Post Market | |
| PENTA-DESIPRAMINE TABLETS | 02232559 | Cancelled (Unreturned Annual) | |
| PENTA-DESIPRAMINE TABLETS | 02232561 | Cancelled (Unreturned Annual) | |
| PENTA-DESIPRAMINE TABLETS | 02232562 | Cancelled (Unreturned Annual) | |
| PENTA-DESIPRAMINE TABLETS | 02232563 | Cancelled (Unreturned Annual) | |
| PENTA-DICLOFENAC - 25MG | 02229591 | Cancelled Post Market | |
| PENTA-DICLOFENAC - 50MG | 02229592 | Cancelled Post Market | |
| PENTA-DILTIAZEM - 30MG | 02229593 | Cancelled (Unreturned Annual) | |
| PENTA-DILTIAZEM - 60MG | 02229594 | Cancelled (Unreturned Annual) | |
| PENTA-DOXYCYCLINE TABLETS | 02231771 | Cancelled (Unreturned Annual) | |
| PENTA-FAMOTIDINE | 02238342 | Cancelled (Unreturned Annual) | |
| PENTA-FAMOTIDINE | 02238343 | Cancelled (Unreturned Annual) | |
| PENTA-FLUOXETINE CAPSULES | 02229819 | Cancelled (Unreturned Annual) | |
| PENTA-FLUOXETINE CAPSULES | 02229820 | Cancelled (Unreturned Annual) | |
| PENTA-FLUTAMIDE | 02233019 | Cancelled (Unreturned Annual) | |
| PENTA-GEMFIBROZIL | 02229604 | Cancelled (Unreturned Annual) | |
| PENTA-GLYBURIDE - 2.5MG | 02229595 | Cancelled Post Market | |
| PENTA-GLYBURIDE - 5MG | 02229596 | Cancelled Post Market | |
| PENTA-IPRATROPIUM BROMIDE | 02239074 | Cancelled (Unreturned Annual) | |
| PENTA-MEDROXYPROGESTERONE TABLETS | 02231768 | Cancelled Post Market | |
| PENTA-MEDROXYPROGESTERONE TABLETS | 02231769 | Cancelled Post Market | |
| PENTA-MEDROXYPROGESTERONE TABLETS | 02231770 | Cancelled Post Market | |
| PENTA-METOPROLOL TABLETS | 02232546 | Cancelled (Unreturned Annual) | |
| PENTA-METOPROLOL TABLETS | 02232547 | Cancelled (Unreturned Annual) | |
| PENTA-OXYBUTYNIN CHLORIDE TABLETS | 02239073 | Cancelled (Unreturned Annual) | |
| PENTA-PIROXICAM CAPSULES | 02232549 | Cancelled (Unreturned Annual) | |
| PENTA-PIROXICAM CAPSULES | 02232550 | Cancelled (Unreturned Annual) | |
| PENTA-SULINDAC | 02239163 | Cancelled (Unreturned Annual) | |
| PENTA-SULINDAC | 02239164 | Cancelled (Unreturned Annual) | |
| PENTA-TAMOXIFEN TABLETS | 02232551 | Cancelled (Unreturned Annual) | |
| PENTA-TAMOXIFEN TABLETS | 02232552 | Cancelled (Unreturned Annual) | |
| PENTA-TEMAZEPAM CAPSULES | 02239071 | Cancelled (Unreturned Annual) | |
| PENTA-TEMAZEPAM CAPSULES | 02239072 | Cancelled (Unreturned Annual) | |
| PENTA-TIAPROFENIC TABLETS | 02231249 | Cancelled (Unreturned Annual) | |
| PENTA-TIAPROFENIC TABLETS | 02231250 | Cancelled (Unreturned Annual) | |
| PENTA-TRAZODONE TABLETS | 02232543 | Cancelled (Unreturned Annual) | |
| PENTA-TRAZODONE TABLETS | 02232544 | Cancelled (Unreturned Annual) | |
| PENTA-TRAZODONE TABLETS | 02232545 | Cancelled (Unreturned Annual) | |
| PENTA-TRIAMTERENE HCTZ TABLETS | 02238638 | Cancelled Post Market | |
| PENTA-TRIAZOLAM TABLETS | 02232553 | Cancelled (Unreturned Annual) | |
| PENTA-TRIAZOLAM TABLETS | 02232554 | Cancelled (Unreturned Annual) | |
| PENTA-VALPROIC CAPSULES | 02231248 | Cancelled (Unreturned Annual) | |
| PENTA-VERAPAMIL - 120MG | 02229598 | Cancelled Post Market | |
| PENTA-VERAPAMIL - 80MG | 02229597 | Cancelled Post Market |
Medical device licences
Active licences first, newest first.
| Name | Licence | Status | First licensed |
|---|---|---|---|
| APC RESISTANCE AND APCR CONTROLS | 106864 | Issued (active) · Class 2 | |
| BATROXOBIN TIME | 106872 | Issued (active) · Class 2 | |
| PEFAKIT APC-R FACTOR V LEIDEN ASSAY | 106742 | Issued (active) · Class 2 |
Notices of Compliance
Newest first.
- PENTA-SULINDACDecember 2, 1998 · NOC 3183 · New Drug Submission (NDS)
- PENTA-OXYBUTYNIN CHLORIDENovember 20, 1998 · NOC 3104 · New Drug Submission (NDS)
- PENTA-BACLOFENNovember 16, 1998 · NOC 2706 · New Drug Submission (NDS)
- PENTA-IPRATROPIUM BROMIDENovember 16, 1998 · NOC 2974 · New Drug Submission (NDS)
- PENTA-TEMAZEPAMNovember 12, 1998 · NOC 3223 · New Drug Submission (NDS)
- PENTA-FAMOTIDINEOctober 7, 1998 · NOC 2895 · New Drug Submission (NDS)
- PENTA-TRIAMTERENCE HCTZAugust 21, 1998 · NOC 3233 · New Drug Submission (NDS)
- PENTA-BUSPIRONEAugust 13, 1998 · NOC 2717 · Abbreviated New Drug Submission (ANDS)
- PENTA-CAPTOPRIL TABLETSFebruary 11, 1998 · NOC 2802 · New Drug Submission (NDS)
- PENTA-AMOXICILLINSeptember 11, 1997 · NOC 3279 · New Drug Submission (NDS)
- PENTA-FLUTAMIDESeptember 4, 1997 · NOC 3814 · New Drug Submission (NDS)
- PENTA-TAMOXIFENAugust 27, 1997 · NOC 4121 · New Drug Submission (NDS)
- PENTA-TRIAZOLAMAugust 27, 1997 · NOC 4167 · New Drug Submission (NDS)
- PENTA-BROMAZEPAMAugust 26, 1997 · NOC 3319 · New Drug Submission (NDS)
- PENTA-CLOBETASOLAugust 26, 1997 · NOC 3669 · New Drug Submission (NDS)
- PENTA-DESIPRAMINEAugust 26, 1997 · NOC 3709 · New Drug Submission (NDS)
- PENTA-METOPROLOLAugust 26, 1997 · NOC 3948 · New Drug Submission (NDS)
- PENTA-PIROXICAMAugust 26, 1997 · NOC 4028 · New Drug Submission (NDS)
- PENTA-TRAZODONEAugust 26, 1997 · NOC 4163 · New Drug Submission (NDS)
- PENTA-DOXYCYCLINEJuly 29, 1997 · NOC 3753 · New Drug Submission (NDS)
- PENTA-MEDROXYPROGESTERONEJuly 23, 1997 · NOC 3930 · New Drug Submission (NDS)
- PENTA-VALPROICMay 15, 1997 · NOC 4106 · New Drug Submission (NDS)
- PENTA-ACEBUTOLOLMay 12, 1997 · NOC 3254 · New Drug Submission (NDS)
- PENTA-AMILORIDE HCTZMay 12, 1997 · NOC 3273 · New Drug Submission (NDS)
- PENTA-TIAPROFENICMay 12, 1997 · NOC 4147 · New Drug Submission (NDS)
- PENTA-FLUOXETINEDecember 3, 1996 · NOC 4412 · New Drug Submission (NDS)
- PENTA-DICLOFENACOctober 4, 1996 · NOC 4341 · New Drug Submission (NDS)
- PENTA-ATENOLOLOctober 2, 1996 · NOC 4217 · New Drug Submission (NDS)
- PENTA-CLOMIPRAMINEOctober 2, 1996 · NOC 4262 · New Drug Submission (NDS)
- PENTA-DILTIAZEMOctober 2, 1996 · NOC 4356 · New Drug Submission (NDS)
- PENTA-GEMFIBROZILOctober 2, 1996 · NOC 4432 · New Drug Submission (NDS)
- PENTA-GLYBURIDEOctober 2, 1996 · NOC 4437 · New Drug Submission (NDS)
- PENTA-VERAPAMILOctober 2, 1996 · NOC 4729 · New Drug Submission (NDS)
- PENTA-AMOXICILLINSeptember 23, 1996 · NOC 4202 · New Drug Submission (NDS)
- PENTA-CEPHALEXINSeptember 23, 1996 · NOC 4307 · New Drug Submission (NDS)